USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial
The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic
The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic
Key findings underscore the need for better control of glycemia, blood pressure and lipid parameters to prevent diabetes-related complications
A centralised kitchen which provides 5,000 breakfast meals per day is to be started at Perumallapuram, Kakinada, Andhra Pradesh
This recommendation is based on new data from two randomized controlled trials involving 3078 patients
The first use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter
Company has invested $150 million to build a 150,000 square-foot commercial manufacturing facility in Research Triangle Park (RTP), North Carolina
Pre-exposure prevention trial reduced risk of symptomatic Covid-19, with no severe disease or Covid-19-related deaths in the Evusheld group
Bringing together Bristol Myers Squibb and Celgene on one clinical trial management system, company goes live with Vault CTMS in record speed
Immune response confirmed in stand-alone influenza vaccine and combination vaccine with a potential path forward for both
The tablets are available in 100 mg strength in bottle count sizes of 60
Subscribe To Our Newsletter & Stay Updated